Acknowledgment of Reviewers
In This Issue
Further Advances in Genetically Informed Lung Cancer Medicine
Intraventricular Chemotherapy for Leptomeningeal Carcinomatosis from Lung Cancer
Surgery in Mesothelioma – Where Do We Go after MARS?
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer
Practice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients
The Effect of Provider Density on Lung Cancer Survival Among Blacks and Whites in the United States
Influence of Postoperative Infectious Complications on Long-Term Survival of Lung Cancer Patients
Genomewide DNA Methylation Analysis Identifies Novel Methylated Genes in Non–Small-Cell Lung Carcinomas
MET and EGFR Mutations Identified in ALK-Rearranged Pulmonary Adenocarcinoma
Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer
Rationale for Chemotherapy, Immunotherapy, and Checkpoint Blockade in SCLC
Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non–Small-Cell Lung Cancer
Visceral Pleural Invasion Classification in Non–Small-Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer
New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Hypofractionated Three-Dimensional Conformal Radiation Therapy Alone for Centrally Located cT1-3N0 Non–Small-Cell Lung Cancer
Comparison of Endobronchial Ultrasound and/or Endoesophageal Ultrasound with Transcervical Extended Mediastinal Lymphadenectomy for Staging and Restaging of Non–Small-Cell Lung Cancer
Sleeve Lobectomy Compared with Pneumonectomy after Induction Therapy for Non–Small-Cell Lung Cancer
Reduced Folate Carrier and Folylpolyglutamate Synthetase, but not Thymidylate Synthase Predict Survival in Pemetrexed-Treated Patients Suffering from Malignant Pleural Mesothelioma
Clinical Impact of Continued Crizotinib Administration after Isolated Central Nervous System Progression in Patients with Lung Cancer Positive for ALK Rearrangement
Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial
Collaterals
Postoperative Proton Therapy in the Management of Stage III Thymoma
Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer
A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib
Early Stage Non–Small-Cell Lung Cancer
Early Stage Non–Small-Cell Lung Cancer
Balancing Radiation Pneumonitis Versus Locoregional Tumor Control in Non–Small-Cell Lung Cancer
Balancing Radiation Pneumonitis Versus Locoregional Tumor Control in Non–Small-Cell Lung Cancer
MARS
MARS
Tomotherapy after Pleurectomy or Decortication or Biopsy for Malignant Pleural Mesothelioma
Tomotherapy after Pleurectomy or Decortication or Biopsy for Malignant Pleural Mesothelioma